A novel risk prediction model for post-treatment ischemic stroke recurrence using plasma antithrombin III and thromboelastography

Yi Cheng, Baobao Huang, Shan Jiang

Open source

DOI
10.5937/jomb0-61916
Published
2026
Container
Journal of Medical Biochemistry
Publisher
Centre for Evaluation in Education and Science (CEON/CEES)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.5937/jomb0-61916,
  title = {A novel risk prediction model for post-treatment ischemic stroke recurrence using plasma antithrombin III and thromboelastography},
  author = {Yi Cheng and Baobao Huang and Shan Jiang},
  year = {2026},
  journal = {Journal of Medical Biochemistry},
  doi = {10.5937/jomb0-61916},
  url = {https://doi.org/10.5937/jomb0-61916}
}

RIS

TY  - JOUR
TI  - A novel risk prediction model for post-treatment ischemic stroke recurrence using plasma antithrombin III and thromboelastography
AU  - Yi Cheng
AU  - Baobao Huang
AU  - Shan Jiang
PY  - 2026
JO  - Journal of Medical Biochemistry
DO  - 10.5937/jomb0-61916
UR  - https://doi.org/10.5937/jomb0-61916
ER  - 

APA

Cheng, Y., Huang, B., & Jiang, S. (2026). A novel risk prediction model for post-treatment ischemic stroke recurrence using plasma antithrombin III and thromboelastography. Journal of Medical Biochemistry. https://doi.org/10.5937/jomb0-61916

Source records